About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
Home
About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
News
NBE Therapeutics in the News
Events
News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Select a year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
November 28 - NBE-Therapeutics obtained CHF 600K SystemsX grant for collaboration with clinical oncologists
Read more
October 8 - NBE-Therapeutics has received CTI-label award by the Swiss Commission for Technology and Innovation (CTI)
Read more
June 16 - NBE-Therapeutics featured by BioCentury as "Emerging Company" in ADC development field
Read more
March 15 - NBE-Therapeutics awarded second CHF 1.0 mio CTI grant
Read more
February 21 - NBE-Therapeutics Announces Validation of its SMAC-Technology for ADC development
Read more
